Morgan Stanley’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$251M Buy
770,968
+129,203
+20% +$42.1M 0.02% 754
2025
Q1
$173M Sell
641,765
-85,459
-12% -$23.1M 0.01% 922
2024
Q4
$171M Buy
727,224
+108,661
+18% +$25.6M 0.01% 919
2024
Q3
$170M Sell
618,563
-122,951
-17% -$33.8M 0.01% 914
2024
Q2
$180M Buy
741,514
+66,233
+10% +$16.1M 0.01% 859
2024
Q1
$101M Sell
675,281
-937,909
-58% -$140M 0.01% 1186
2023
Q4
$309M Buy
1,613,190
+403,807
+33% +$77.3M 0.01% 891
2023
Q3
$214M Sell
1,209,383
-671,423
-36% -$119M 0.02% 663
2023
Q2
$357M Buy
1,880,806
+649,991
+53% +$123M 0.04% 490
2023
Q1
$247M Sell
1,230,815
-159,825
-11% -$32M 0.03% 621
2022
Q4
$330M Sell
1,390,640
-108,119
-7% -$25.7M 0.04% 488
2022
Q3
$300M Buy
1,498,759
+370,144
+33% +$74.1M 0.04% 437
2022
Q2
$165M Buy
1,128,615
+279,958
+33% +$40.8M 0.02% 677
2022
Q1
$139M Sell
848,657
-217,032
-20% -$35.4M 0.02% 677
2021
Q4
$181M Sell
1,065,689
-815,190
-43% -$138M 0.02% 606
2021
Q3
$355M Sell
1,880,879
-1,772
-0.1% -$335K 0.05% 349
2021
Q2
$319M Buy
1,882,651
+96,697
+5% +$16.4M 0.04% 384
2021
Q1
$252M Buy
1,785,954
+94,114
+6% +$13.3M 0.04% 416
2020
Q4
$220M Buy
1,691,840
+171,490
+11% +$22.3M 0.03% 440
2020
Q3
$221M Buy
1,520,350
+10,479
+0.7% +$1.53M 0.04% 354
2020
Q2
$224M Buy
1,509,871
+124,671
+9% +$18.5M 0.05% 324
2020
Q1
$151M Sell
1,385,200
-155,616
-10% -$16.9M 0.04% 385
2019
Q4
$177M Buy
1,540,816
+177,298
+13% +$20.4M 0.04% 405
2019
Q3
$110M Buy
1,363,518
+26,397
+2% +$2.12M 0.03% 528
2019
Q2
$97M Buy
1,337,121
+116,760
+10% +$8.47M 0.03% 564
2019
Q1
$114M Buy
1,220,361
+37,462
+3% +$3.5M 0.03% 498
2018
Q4
$86.2M Sell
1,182,899
-54,587
-4% -$3.98M 0.03% 573
2018
Q3
$108M Sell
1,237,486
-19,556
-2% -$1.71M 0.03% 570
2018
Q2
$124M Sell
1,257,042
-3,381
-0.3% -$333K 0.03% 492
2018
Q1
$150M Buy
1,260,423
+91,652
+8% +$10.9M 0.04% 423
2017
Q4
$148M Buy
1,168,771
+188,948
+19% +$24M 0.04% 446
2017
Q3
$115M Sell
979,823
-37,708
-4% -$4.43M 0.03% 499
2017
Q2
$81.2M Buy
1,017,531
+315,795
+45% +$25.2M 0.02% 660
2017
Q1
$36M Sell
701,736
-110,448
-14% -$5.66M 0.01% 1118
2016
Q4
$30.4M Sell
812,184
-28,228
-3% -$1.06M 0.01% 1190
2016
Q3
$57M Sell
840,412
-34,692
-4% -$2.35M 0.02% 775
2016
Q2
$48.6M Sell
875,104
-203,778
-19% -$11.3M 0.02% 813
2016
Q1
$67.7M Sell
1,078,882
-18,043
-2% -$1.13M 0.03% 617
2015
Q4
$103M Sell
1,096,925
-115,371
-10% -$10.9M 0.04% 474
2015
Q3
$97.4M Sell
1,212,296
-84,961
-7% -$6.83M 0.04% 479
2015
Q2
$156M Sell
1,297,257
-102,268
-7% -$12.3M 0.05% 379
2015
Q1
$146M Buy
1,399,525
+24,119
+2% +$2.52M 0.05% 375
2014
Q4
$133M Buy
1,375,406
+513,571
+60% +$49.8M 0.05% 417
2014
Q3
$67.3M Sell
861,835
-5,784
-0.7% -$452K 0.03% 685
2014
Q2
$54.8M Buy
867,619
+128,433
+17% +$8.11M 0.02% 751
2014
Q1
$49.6M Sell
739,186
-2,379
-0.3% -$160K 0.02% 747
2013
Q4
$47.7M Buy
741,565
+550,847
+289% +$35.4M 0.02% 760
2013
Q3
$12.2M Buy
190,718
+137,477
+258% +$8.8M 0.01% 1609
2013
Q2
$1.65M Buy
+53,241
New +$1.65M ﹤0.01% 3313